AVI completes purchase of GMP manufacturing site
The 34,000-square-foot facility will house additional capability for the large-scale GMP production of AVI’s proprietary phosphorodiamidate morpholino oligomers (PMOs). Additional capacity for both of these processes will be
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.